mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.008 |
mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
-0.093 |
0.008 |
mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.008 |
mRNA |
Gefitinib |
GDSC1000 |
pan-cancer |
AAC |
0.094 |
0.009 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.009 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.009 |
mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.009 |
mRNA |
BRD-K97651142 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.01 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.01 |
mRNA |
YM201636 |
GDSC1000 |
pan-cancer |
AAC |
-0.087 |
0.01 |